[StP-03] Students and Junior Residents Poster Session 03

[StP-03-3] A case of APS type3 with MS who developed T1DM triggered by the COVID-19 vaccine

Asaki Tsuru¹, Shusuke Koto^1,2, Kenta Hara³, Yuuya Miyazaki², Keisuke Kugo¹, Jun Kouduki¹, Rei Hashimoto¹, Masahiro Shimomura¹, Kiminobu Okayama¹, Masashi Hosomi⁴, Tetsuya Oda¹, Hirotoshi Hamaguchi¹ (1.Department of Neurology, Kita-harima Medical Center, Japan, 2.Division of Neurology, Kobe University Graduate School of Medicine, Japan, 3.Department of Diabetes and Endocrine disease, Kita-harima Medical Center, Japan, 4.Department of Rehabilitation, Kita-harima Medical Center, Japan)